Matches in Wikidata for { <http://www.wikidata.org/entity/Q91661773> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q91661773 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91661773 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91661773 description "scientific article published on 31 May 2019" @default.
- Q91661773 description "wetenschappelijk artikel" @default.
- Q91661773 description "наукова стаття, опублікована 31 травня 2019" @default.
- Q91661773 name "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 name "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 type Item @default.
- Q91661773 label "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 label "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 prefLabel "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 prefLabel "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 P1433 Q91661773-1401D304-B04F-4416-B0B6-07B7BF16CEA6 @default.
- Q91661773 P1476 Q91661773-BBD769C0-5328-4DCC-968E-461341C2D78D @default.
- Q91661773 P304 Q91661773-903036B3-68B2-4689-B491-F79D536A2307 @default.
- Q91661773 P31 Q91661773-CECE9B09-ABE4-4B60-B244-EBE50CA25847 @default.
- Q91661773 P356 Q91661773-820DFA62-D9B7-477C-9675-1915D44C8525 @default.
- Q91661773 P433 Q91661773-7A675629-04CD-4597-BC53-6304DA695F8A @default.
- Q91661773 P478 Q91661773-B8F897AB-A650-4399-919E-2F450EF504E2 @default.
- Q91661773 P577 Q91661773-486C8DAC-719F-45CB-86B6-9972D731EE0F @default.
- Q91661773 P698 Q91661773-3F8B7275-6258-4E58-A18B-ABEDF65C232C @default.
- Q91661773 P921 Q91661773-3F338DE4-DBC9-424C-A9BC-A1D10E6CC161 @default.
- Q91661773 P921 Q91661773-929AE1CA-E4E2-4AB7-90BD-98A600E22D9D @default.
- Q91661773 P356 J.JVAL.2019.05.002 @default.
- Q91661773 P698 31277833 @default.
- Q91661773 P1433 Q15766908 @default.
- Q91661773 P1476 "Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States" @default.
- Q91661773 P304 "843" @default.
- Q91661773 P31 Q13442814 @default.
- Q91661773 P356 "10.1016/J.JVAL.2019.05.002" @default.
- Q91661773 P433 "7" @default.
- Q91661773 P478 "22" @default.
- Q91661773 P577 "2019-05-31T00:00:00Z" @default.
- Q91661773 P698 "31277833" @default.
- Q91661773 P921 Q412616 @default.
- Q91661773 P921 Q974135 @default.